http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110041318-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-14 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4545 |
| filingDate | 2018-01-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-110041318-B |
| titleOfInvention | A class of dopamine D5 receptor agonists and their preparation and application |
| abstract | The present invention provides a class of dopamine D5 receptor agonists and their preparation and application. Specifically, the present invention provides the bisthiophene methylene substituted 5-hydroxytryptamine carbamate derivatives as shown in formula I, or their pharmacy acceptable salts, racemates, R-isomers, S-isomers above, the present invention also provides a preparation method of such compounds or their pharmaceutically acceptable salts. The present invention also provides the use of the compound in preparing a medicament for treating attention deficit hyperactivity disorder. |
| priorityDate | 2018-01-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 114.